Telix Pharmaceuticals | TLX - Sales Revenues

Stock Price
9.85
Daily Change
-0.28 -2.76%
Monthly
-10.54%
Yearly
-65.99%
Q1 Forecast
10.34

Telix Pharmaceuticals reported AUD309.72M in Sales Revenues for its fiscal semester ending in June of 2025.





Sales Change Date
Cochlear AUD 585.65M 586.15M Jun/2025
CSL USD 3.54B 4.68B Jun/2025
Integral Diagnostics AUD 238.44M 7.19M Jun/2024
Mayne Pharma AUD 195.04M 20.71M Jun/2025
Medical Developments International AUD 9.53M 1.99M Jun/2025
Mesoblast USD 13.2M 10.04M Jun/2025
Neuren Pharmaceuticals AUD 14.14M 179.96M Jun/2025
Pacific Edge NZD 5.94M 4.95M Dec/2025
Paradigm Biopharmaceuticals AUD -8K 441.66K Jun/2025
Polynovo AUD 34.58M 24.94M Jun/2025
PYC Therapeutics AUD 13.48M 786.97K Jun/2025
Ramsay Health Care AUD 9.29B 32.2M Dec/2025
ResMed USD 1.42B 87.23M Dec/2025
Sonic Healthcare AUD 4.98B 311M Jun/2025